GL1X · GenesisL1 explorer

Research workbench

Identification of novel allosteric inhibitors of hepatitis C virus NS5B polymerase thumb domain (site II) by structure-based design

Analyse Identification of novel allosteric inhibitors of hepatitis C virus NS5B… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2WRM
Type
protein
Length
531 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
RNA-directed RNA polymerase
EC
2.7.7.48
UniProt
P26663
Ligands
QQ3
Pockets
8 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 51% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARNA-directed RNA polymerase (EC 2.7.7.48)protein53151% helix, 15% strandP26663

Ligands and binding sites

  • QQ3 · (3R)-3-(4-methyl-1,3-dioxo-1,3-dihydro-2H-pyrrolo[3,4-c]quinolin-2-yl)hexanoic acid · ligand · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18740.730.7782empty
21170.500.8017empty
3670.390.7917empty
41140.390.7525empty
5840.350.7612empty

Compared structures

  • 2WRM · Identification of Novel Allosteric Inhibitors of Hepatitis C Virus NS5B Polymerase Thumb… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.